A DOUBLE-BLIND COMPARISON OF ACUTE BUPRENORPHINE WITH PLACEBO IN SCHIZOPHRENIA

被引:0
|
作者
NUTT, DJ
GROVES, S
机构
[1] UNIV BRISTOL,DEPT MENTAL HLTH,BRISTOL BS8 1TD,AVON,ENGLAND
[2] BARROW HOSP,BRISTOL,ENGLAND
关键词
D O I
10.1016/0920-9964(92)90142-R
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:113 / 113
页数:1
相关论文
共 50 条
  • [21] A DOUBLE-BLIND COMPARISON OF TRAMADOL AND BUPRENORPHINE IN THE CONTROL OF POSTOPERATIVE PAIN
    ALON, E
    SCHULTHESS, G
    AXHAUSEN, C
    HOSSLI, G
    ANAESTHESIST, 1981, 30 (12): : 623 - 626
  • [22] SUBLINGUAL BUPRENORPHINE AS POSTOPERATIVE ANALGESIC - A DOUBLE-BLIND COMPARISON WITH PETHIDINE
    MOA, G
    ZETTERSTROM, H
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1990, 34 (01) : 68 - 71
  • [23] DOUBLE-BLIND TRIAL OF BACLOFEN AGAINST PLACEBO IN TREATMENT OF SCHIZOPHRENIA
    GULMANN, NC
    BAHR, B
    ANDERSEN, B
    ELIASSEN, HMM
    ACTA PSYCHIATRICA SCANDINAVICA, 1976, 54 (04) : 287 - 293
  • [24] DOUBLE-BLIND COMPARISON BETWEEN LOXAPINE AND HALOPERIDOL BY PARENTERAL ROUTE IN ACUTE SCHIZOPHRENIA
    PAPROCKI, J
    VERSIANI, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 21 (01): : 80 - 100
  • [25] DOUBLE-BLIND COMPARISON OF FLUPHENAZINE DECANOATE AND FLUPENTHIXOL DECANOATE IN TREATMENT OF ACUTE SCHIZOPHRENIA
    JOHNSON, DAW
    MALIK, NA
    ACTA PSYCHIATRICA SCANDINAVICA, 1975, 51 (04) : 257 - 267
  • [26] A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia
    Meltzer, Herbert Y.
    Risinger, Robert
    Nasrallah, Henry A.
    Du, Yangchun
    Zummo, Jacqueline
    Corey, Lisa
    Bose, Anjana
    Stankovic, Srdjan
    Silverman, Bernard L.
    Ehrich, Elliot W.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (08) : 1085 - +
  • [27] Quetiapine in patients with schizophrenia - A high- and low-dose double-blind comparison with placebo
    Small, JG
    Hirsch, SR
    Arvanitis, LA
    Miller, BG
    Link, CGG
    Murphy, AL
    Bowden, CL
    OBrien, CP
    Steinbook, RM
    Wagner, RL
    Pitts, WM
    Crabtree, B
    Corrigan, MHN
    Lohr, JB
    Miller, AL
    Ereshefsky, L
    Anderson, CB
    Knesevich, MA
    Rotrosen, J
    Owen, RR
    Karson, CN
    Lindenmayer, JP
    Pfefferbaum, A
    Faustman, WO
    Keck, PE
    Patterson, WM
    Riesenberg, RA
    Gladson, MB
    Kolin, IS
    Barnes, TRE
    Sensky, T
    Riccio, M
    Franks, S
    Jolley, A
    Hallstrom, C
    Bennie, E
    Darcourt, G
    Patris, M
    DeSilva, M
    Patel, AG
    Fleischhacker, WW
    Dietzel, M
    Seifertova, D
    Vinar, O
    Faltus, F
    Bitter, I
    Ozsvath, K
    Shaw, SH
    Mahapatra, SN
    Szulecka, TK
    ARCHIVES OF GENERAL PSYCHIATRY, 1997, 54 (06) : 549 - 557
  • [28] DOUBLE-BLIND COMPARISON OF HALOPERIDOL ORAL CONCENTRATE, HALOPERIDOL SOLUTABS AND PLACEBO IN TREATMENT OF CHRONIC SCHIZOPHRENIA
    OTA, KY
    KURLAND, AA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (2-3): : 99 - 110
  • [29] DOUBLE-BLIND COMPARISON OF NAMOXYRATE CODEINE ASPIRIN AND PLACEBO
    CORGILL, DA
    LIGON, CW
    DEFELICE, EA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1965, 7 (05): : 263 - +
  • [30] DOUBLE-BLIND COMPARISON OF BROMOCRIPTINE AND PLACEBO IN COCAINE WITHDRAWAL
    EILER, K
    SCHAEFER, MR
    SALSTROM, D
    LOWERY, R
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1995, 21 (01): : 65 - 79